Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1999
11/18/1999WO1999058540A2 1-galactose derivatives
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058478A1 Novel derivatives of 3,3-diphenylpropylamines
11/18/1999WO1999058154A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
11/18/1999WO1999058143A1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
11/18/1999WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/18/1999WO1999058133A2 Anti-diarrheal and method for using the same
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999049888A3 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331569A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2331314A1 Anti-diarrheal and method for using the same
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330484A1 1-galactose derivatives
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330000A1 Diagnosis and treatment of hepatic disorders
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2288993A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999EP0957091A1 Inhibitors of tumor necrosis factor alpha
11/17/1999EP0957073A1 Novel derivatives of 3,3-diphenylpropylamines
11/17/1999EP0956864A1 Tissue fibrosis inhibitor
11/17/1999EP0956861A1 Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having chronic hepatitis c infection
11/17/1999EP0956857A2 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
11/17/1999EP0956856A2 Calcium assimilation accelerator, calcium supplementing diet and method for accelerating calcium assimilation
11/17/1999EP0956285A1 Novel genipin derivative having anti hepatitis b virus activity
11/17/1999EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
11/17/1999EP0956007A1 Chewing gum containing colloidal bismuth subcitrate
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235599A Biphenyl dicarboxylic acid derivatives and preparation thereof
11/17/1999CN1235552A Beta-glucan products and extration from cereals thereof
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235030A Composite oral liquid of Gaolining and preparing method thereof
11/17/1999CN1046515C Diazabicyclic neurokinin antagonists
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/17/1999CN1046506C Preparation of n-tert-butylamides derivatives and their salts
11/16/1999US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985845 Methods for reducing mortality rates in poultry
11/16/1999US5985826 Methods of using hepatic-directed compounds in pretargeting strategies
11/16/1999US5985823 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
11/16/1999US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999CA2120215C 2,3-dihydro-4(1h)-quinazolinones active in gastro-intestinal pathologies
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999057100A1 Spla2 inhibitor compounds for treatment of disease
11/11/1999WO1999056781A1 Methods of using isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056780A1 Isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056772A2 Hepatitis vaccine
11/11/1999WO1999056769A2 Inhibition of helicobacter pylori proliferation
11/11/1999WO1999056767A2 Method for treating cytokine mediated hepatic injury
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056762A1 Preventives and ameliorating agents for periodontosis
11/11/1999WO1999056748A1 Desmethylpantoprazole compositions and methods
11/11/1999WO1999056746A1 Hydroxyomeprazole compositions and uses
11/11/1999WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology
11/11/1999WO1999056725A1 Pharmaceutical compositions capable of being gelled
11/11/1999WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999WO1999045916A3 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1999040073A3 Tryptase inhibitors
11/11/1999DE19805815C1 Diagnostikum zum Erkennen der autoimmunen Hepatitis Diagnostic tool for the detection of autoimmune hepatitis
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2330856A1 Spla2 inhibitor compounds for treatment of disease
11/11/1999CA2330049A1 Hydroxyomeprazole compositions and uses
11/11/1999CA2329925A1 Desmethylpantoprazole compositions and methods
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
1 ... 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 ... 1258